期刊
BMJ OPEN
卷 11, 期 12, 页码 -出版社
BMJ PUBLISHING GROUP
DOI: 10.1136/bmjopen-2021-054286
关键词
anxiety disorders; depression & mood disorders; public health; mental health
资金
- project integrated in Plan Estatal de I+D+I 2017-2020 [PI20/00697]
- ISCIII-Subdireccion General de Evaluacion y Fomento de la investigacion del Fondo Europeo de Desarrollo Regional (FEDER), Otra manera de hacer Europa
- Gobierno de Aragon
- FEDER 2014-2020 'Construyendo Europa desde Aragon' [S31_20D]
Emotional disorders are prevalent, yet often undertreated. This study aims to evaluate the effectiveness and cost efficiency of blended treatments using the Unified Protocol for the Transdiagnostic Treatment of EDs across multiple disorders.
Introduction Emotional disorders (EDs) have become the most prevalent psychological disorders in the general population, which has boosted the economic burden associated with their management. Approximately half of the individuals do not receive adequate treatment. Consequently, finding solutions to deliver cost-effective treatments for EDs has become a key goal of today's clinical psychology. Blended treatments, a combination of face-to-face and online interventions, have emerged as a potential solution to the previous. The Unified Protocol for the Transdiagnostic Treatment of EDs (UP) might serve this purpose, as it can be applied to a variety of disorders simultaneously and its manualised format makes it suitable for blended interventions. Methods and analysis The study is a multicentre, randomised, superiority, clinical trial. Participants will be 310 individuals with a diagnosis of an ED. They will be randomised to a treatment as usual (individual cognitive behavioural therapy) or a UP condition in a blended format (face-to-face individual UP +online, app-based UP). Primary outcomes will be ED diagnostic criteria and depression and anxiety symptoms. Cost efficiency of the intervention, app usability, as well as opinion and confidence in the treatment will also be evaluated. Assessment points will include baseline and 3 months, 6 months and 12 months after UP treatment. Ethics and dissemination The study has received approvals by the Ethics Research Committee of Navarra, Castellon, Euskadi, Castilla y Leon, Extremadura, Lleida and Aragon. The study is currently under an approval process by the Ethics Research Committees of all the remaining collaborating centres. Outcomes will be disseminated through publication in peer-reviewed journals and presentations at international conference meetings.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据